Columbia Care Inc
F:3LP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bay Capital PLC
LSE:BAY
|
JE |
|
Sogeclair SA
PAR:SOG
|
FR |
|
ShanXi Coking Co Ltd
SSE:600740
|
CN |
|
Sterling Group Holdings Ltd
HKEX:1825
|
HK |
Columbia Care Inc
Operating Expenses
Columbia Care Inc
Operating Expenses Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Columbia Care Inc
F:3LP
|
Operating Expenses
-$277.3m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
-49%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Operating Expenses
-$38.6B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-3%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Operating Expenses
-$17.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
7%
|
CAGR 10-Years
-5%
|
|
|
Pfizer Inc
NYSE:PFE
|
Operating Expenses
-$27.5B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
-1%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Operating Expenses
-$26.2B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-5%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Operating Expenses
-$24.4B
|
CAGR 3-Years
-21%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-8%
|
|
Columbia Care Inc
Glance View
Columbia Care, Inc. engages in the cultivation, manufacture and provision of medical cannabis products and services. The company is headquartered in New York City, New York. The company went IPO on 2019-04-29. The firm is engaged cultivating, manufacturing and providing medical and adult use cannabis products and related services with licenses in over 18 the United States jurisdictions and the European Union (EU). The firm operates facilities including dispensaries and cultivation and manufacturing facilities. The firm operates as the original providers of medical cannabis in the United States and continues to deliver a patient-centered medicinal cannabis operation. The firm offers products spanning flower, edibles, oils, and tablets, and manufactures brands including Seed & Strain, Amber and Platinum Label Cannabidiol (CBD) products. The company develops products which comprised of a variety of medical and adult-use form factors, including but not limited to formulations, precision manufactured dosing and cannabis flower and flower-derived products.
See Also
What is Columbia Care Inc's Operating Expenses?
Operating Expenses
-277.3m
USD
Based on the financial report for Dec 31, 2022, Columbia Care Inc's Operating Expenses amounts to -277.3m USD.
What is Columbia Care Inc's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-49%
Over the last year, the Operating Expenses growth was -20%. The average annual Operating Expenses growth rates for Columbia Care Inc have been -29% over the past three years , -49% over the past five years .
